Journal of Drug Metabolism & Toxicology

Journal of Drug Metabolism & Toxicology
Open Access

ISSN: 2157-7609

+44-77-2385-9429

Review Article - (2016) Volume 7, Issue 2

Microbial Transformations of Plant Origin Compounds as a Step in Preparation of Highly Valuable Pharmaceuticals

Blaga Mutafova1*, Sava Mutafov1, Pedro Fernandes2 and Strahil Berkov3
1The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria
2Universidade Lusofona de Humanidades e Tecnologias, Lisboa, Portugal
3Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, Sofia, Bulgaria
*Corresponding Author: Blaga Mutafova, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria, Fax: +359 2 870 01 09,

Abstract

The aim of the paper is to present microbial transformation reactions as a step in the preparation of drugs or their key intermediates from plant derived compounds. Described are some successful applications of microbial transformation processes for preparation of steroid drugs and/or their important intermediates as well as some microbial transformations of terpenes, alkaloids, flavonoids and poly(phenols) affording derivatives with improved biological activities.

Keywords: Microbial transformation; Phytosterols; Steroids; Terpenes; Alkaloids; Flavonoids; (Poly)Phenols

Introduction

From ancient times to recent days plants have been subjected to different manipulations to obtain biologically active compounds for medical purposes. Methods applied range from traditional extractions to environmental friendly techniques including extraction with ionic liquids, microwave-assisted and ultrasound-assisted extraction, solid phase extraction and supercritical fluid extraction [1-3]. Additionally, acid or enzymatic hydrolysis may be applied in order to make the active ingredients available for the intended clinical applications [4,5]. The plant derived compounds are also subjected to processes of microbial transformation which are nowadays considered as promising technologies for drug development and improvement [6-9]. The microbial transformations are carried out in mild conditions, proceed with high regio- and stereo-specificity and give rise to derivatives which are either difficult to be prepared by chemical means or not economically reasonable. In the recent years the interest in microbial transformations of plant derived biologically active compounds affected even the alternative medicine. Some traditional Chinese medicinal herbs and their ingredients were subjected to biotransformations as well [10,11].

The microbial transformation process

Klaus Kieslich defined the biotransformation processes as “chemical reactions by microorganisms or enzymes” [12]. Several requirements were further on added to this definition aiming to distinguish the microbial transformation processes from these of bioconversion and biodegradation, i.e. the substrate should be a foreign to the microbial cell compound as well as at least one of the products should keep the structure of the substrate unchanged [13]. Actually, the definition of the microbial transformation process was refined primarily based on studies dealing with microbial transformations of steroid compounds and these processes gained their recent importance due to their successful application in steroid drug manufacturing [14,15].

Microbial transformation reactions and the steroid drug story

Microbial transformation reactions of phytosterols include as a first step their side-chain cleavage as well as processes of hydroxylation and dehydrogenation of the steroid ring structure and isomerization of the double bonds. It is important to highlight that any of the positions of the steroid ring is prone to microbial attack, either bacterial or fungal. In general, bacteria are more active in complete steroid structure degradation while fungi are much more active in multiple steroid hydroxylations. However, despite of the attempts that have been made to find out which microorganisms are best in performing each type of the transformation reaction, no proper correlation between the type of substrate, taxonomic position of the microorganism and the reaction performed has been established. It is worth mentioning the Akhrem and Titov’s classical book “Steroids and microorganisms” in which the authors returned back to 1913 when the first studies on microbial (Mycobacterium) cleavage of the cholesterol molecule were performed. The same investigation was marked as a starting point in studies on a large group of microbial transformation reactions proceeding with cleavage of carbon-carbon bonds and leading to partial or full splitting of the steroid molecule [16]. Later on huge amounts of data on diversity of microorganisms revealing steroid transformations activities were collected and made available [17-25].

The era of practical application of microorganisms in the large-scale process of manufacturing of steroid drugs and/or their key intermediates began with the discovery of the ability of a Rhizopus strain to introduce oxygen in the molecule of progesterone made by Peterson and Murrey [26]. In the Proceeding of The International Symposium on the History of Steroid Chemistry held in New York City in 1991, representatives of the pharmaceutical companies involved in the early stages of steroid drug manufacturing like Upjohn [27], Merck [28], Schering [29], Searle [30], Squibb [31], Syntex [32] presented their point of view. As seen from what participants in development of the steroid drug story told firsthand, a lot of knowledge had been accumulated and lot of specialists had been involved as the steroid drug manufacturing to become possible. “From 1927 to 1984 fifteen Nobel prizes were awarded out of research work involving sterols” [33]. Among these Nobel Prizes, the one in Medicine and Physiology from 1950 was awarded for discoveries regarding the hormones of the adrenal cortex, their structure, and biological effects [34]. Thus, through discovery of cortisone and its activity against the rheumatoid arthritis, the chemist Edward Kendall, the clinic physician Philip Hench and the professor of pharmaceutical chemistry Tadeusz Reichstein paved the way towards the forthcoming successful steroid drug story. Of key importance in this story was to find out an available and cheap raw material to serve as precursor in large scale production.

The breakthrough was made by Russel Marker, a brilliant chemistry professor conducting research on sapogenins who concentrated his attention on the chemistry of the steroid sapogenin diosgenin, present in certain inedible yams growing wild in Mexico. His efforts in the area led to the formation in 1944 of the Syntex Company to produce progesterone from diosgenin in Mexican yams by a four-step process now known as Marker degradation [35]. Almost at the same time, in the early 1950s Glaxo started in UK production of cortisone from hecogenin from Agave family plants [36] while Upjohn concentrated on production of progesterone from sitosterol [37].

Simultaneously, the enzymatic transformations of steroids evolved as a particularly important new dimension in the steroid research at Upjohn during 1949 [27] where the microbiologist Herbert C. Murrey and the biochemist Durey H. Peterson made together a history-making discovery: progesterone was the first steroid transformed microbially by Rhizopus nigricansstrain [26]. On this occasion Carl Djerassi, the inventor of the anti-baby pill, named also Father of the Pill, confessed that “what we chemists had accomplished laboriously through a series of complicated chemical conversions, Upjohn’s microorganism with its own enzymes did in a single step” [35]. It is worth reading the Fifth David Perlman Memorial Lecture presented by William Maxon [37] as well as John Hogg’s vision on Upjohn steroid [27] to get further details on the intriguing events happened within the Upjohn steroid community during the golden age of steroids.

Microbial transformation reactions of importance in steroid drugs manufacturing comprise phytosterols side-chain cleavage, 9α-steroid hydroxylation, hydroxylations at 11 and 16 position and dehydrogenation at 1-2 position.

The microbial process of β-sitosterol side-chain cleavage

This process leads to formation of androstenedione (AD) and androstadienedione (ADD) which are key intermediates in steroid drug manufacturing [38,39]. The process has been carried out with immobilized cells [40-42], with micronized substrate [43], in organic medium [44,45], in the presence of water-miscible solvents [46], in microemulsions [47], in liquid polymer medium, e.g. silicone oil [48], in two-phase aqueous-organic solvent media [49,50], in two-phase aqueous-vegetable oils medium [51], in two-phase aqueous-liquid polymer, e.g. silicone oil, polypropylene glycol, polyethylene glycol [43,52-54], with phytosterols encapsulated in cyclodextrins [55-59] and in cloud point systems, which involve the use of nonionic surfactants [60].

9α-hydroxylation of steroids

The importance of the 9α-steroid hydroxylation reaction is due to fact that it opens the way for the fluorination at the same position which can be achieved chemically and which further increases the anti-inflammatory potency of the preparations [61]. The introduction of hydroxyl function at C9 unlocks the way to opening the ring B of the steroid structure. Best studied is the process of 9α-hydroxylation of androstenedione by Rhodococcus sp. which is also capable of introducing hydroxyl function at C9 position of 5α-H -steroids of the 5α-H -androstane and 5α-H -pregnane steroids despite the lack of Δ4-3- keto- configuration [14,20,21,62,63]. Detailed investigations on the enzymes have shown that 9α-hydroxylase consisted of a multimeric two component Rieske type non-heme oxygenase [64]. The androstenedione might be attacked either by 9α-steroid hydroxylase with formation of 9α-hydroxy-androstenedione or by Δ1-steroid dehydrogenase with formation of androstadienedione. Both enzymes normally exist in bacteria and due to their activity steroid ring is cleaved and further degraded. As usually one of these activities prevails, this leads to accumulation of one of the products, 9α- hydroxy-androstenedione [65] or androstadienedione [66] which are further used for synthesis of diuretics, anabolics, estrogens and anticancer drugs [14,38].

The consecutive induction of 9α-steroid hydroxylase and Δ1-steroid dehydrogenase in resting Rhodococcus sp. cells was used to prevent the degradation of the accumulated in the reaction medium 9α- hydroxy-androstenedione [67]. The process of 9α-hydroxylation of androstenedione was successfully performed in the presence of Tween 80 [68] as well as in an organic solvent media [69].

Hydrocortisone and the ways to it

There are two possibilities to get to hydrocortisone employing microbial steps– directly through microbial 11β-hydroxylation of the Reichstein’s compounds “S” (cortexolone) which on its turn is prepared by chemical means from progesterone; and indirectly through microbial 11α-hydroxylation of progesterone followed by six chemical steps. As in any of the cases both chemical and microbial steps are involved, the decision on which way to choose depends on a large extent on the activity of microorganisms.

For progesterone 11α-hydroxylation employed are Rhizopus nigricans , Rhizopus arrhizus and Aspergillus ochraceus [70,71]. To underline the importance of the conditions at which microbial transformation processes are performed (pH, temperature, aeration etc.) it is interesting to mention that the discovery of Murray and Peterson might have been put off for some time, if they were applied more rapid stirring as it was shown later that at higher aeration Rhizopus nigricans transforms progesterone in dihydroxyprogesterone as a single product [27]. For 11β-hydroxylation of cortexolone Curvularia lunata is usually the preferred choice, although Cunninghamella blakesleeana, C. echinulata and C. echinulata have also been used [72-77].

There are a lot of studies devoted to the processes of 11α- hydroxylation of progesterone and 11β-hydroxylation of cortexolone or their derivatives. Employed are free and immobilised [78-82], growing and resting cells [75-77,83], reactions are performed in microchannels [84] etc. Reported in the literature are details regarding inducibility of steroid hydroxylases [85], application of cyclodextrins [55] and crystalline substrates [86] in processes aimed at improving their effectiveness.

The importance of the oxygen function at 11position is also due to the possibility which it opens for introducing by chemical means of fluorine in the ring B which further enhances anti-inflammatory activity of the obtained steroid [12].

Δ1-steroid dehydrogenation

The introduction of 1-2 double bond in ring A of hydrocortisone and cortisone creates derivatives with improved anti-inflammatory properties and reduced undesirable side effects. Arthur Nobile and his team from Schering Corporation discovered that cortisone can be oxidized to prednisone by the bacterium Corynebacterium simplex [87]. Prednisolone was also synthesized at Schering. Both, prednisone and prenisolone revealed antiarthritic activity and absence of significant associated salt retention [29]. Elegant chemical research at Upjohn led also to 6α-methylprednisolone, the clinically important Medrol [27].

16-substituted steroid drugs

16α-hydroxylated compounds retain glucocorticoid activity without concomitant salt and fluid retention while 16β-methylation further increases the anti-inflammatory activity of steroid drugs [61]. The 16α- hydroxylation of progesterone was accomplished at Squibb by an unidentified Actinomycete strain in the same year of the phenomenal success of the Upjohn chemists Murrey and Peterson [88].

Leader in studying and development of 16-substituted corticoids was Lederle with its research on 16-oxygenated steroids culminating in the synthesis and therapeutic use of triamcinolone and related compounds [89]. The Squibb process for the production of triamcinolone is based on microbial 16α-hydroxylation of 9α- fluorohydrocortisone and 9α-fluoroprednisolone performed by Streptomyces roseochromogenus [90].

16β-methylated steroid drugs were almost simultaneously reported by Merck and Schering, betamethasone being another highly potent glucocorticoid devoid of salt retention [28].

Microbial 16-hydroxylation activity was reported in Aspergillus niger by introducing the hydroxyl function directly at 16β-position of 17-oxo-steroids [91] and in Streptomyces roseochromogenus at 16α- position of progesterone [92]. Nocardia farcinica IFM 10152 displayed 16α-hydroxylation activity, a feature ascribed to the bacterial P450 monooxygenase CYP154C5 which in turns can be exploited to obtain 16α-hydroxylated steroids at preparative scale [93].

9α-fluorosteroids and their place in the steroid drug industry

The merit for the discovery of fluorosteroids belongs to Squibb chemists and a patent was issued in 1958 [94]. The recollections of John Fried regarding events leading to first synthesis of 9α- fluorosteroids and how their potential was revealed present an impressive reading. As he mentioned, nobody at Squibb really believed that this would be of great interest, since no fluorine-containing drug had ever reached the market, even more fluoroacetate was a highly toxic enzyme inhibitor. Interestingly, 9α-bromocortisol and 9α- iodocortisol obtained from 11-epicortisol had one third and one tenth of the activity of cortisol, respectively. Most unexpectedly, 9α- chlorocortisol was shown to possess the appreciable (3.5 x Cortisol) activity while the 9α-fluorocortisol turned out to be a superglucocorticoid with 10 times higher activity of cortisol,possessing as well activity equal to the mineralcorticoid hormone aldosterone, at that time a laboratory curiosity [31].

Combinations of steroid transforming reactions

Combining processes of 9α- and 11-hydroxylation, 1-2 dehydrogenation and 16α-methylation with fluorination led to further development of powerful not-salt retaining anti-inflammatory chemical analogues hydrocortisone, prednisolone, dexamethasone, betamethasone etc., presented on Figure 1.

drug-metabolism-toxicology

Figure 1: Pregnane skeleton and some steroid drugs which manufacturing involves microbial steps like hydroxylation at C9, C11 and C16, and dehydrogenation at C1-C2.

It is important to notice that they are still irreplaceable in medicine despite of being denied and blamed for different reasons.

Microbial transformation of terpenes

Terpenes have always been in the focus of investigations due to their wide applications in the flavor and fragrance industry, as well as because of their potential for further biotechnological developments as pharmaceutical agents and insecticides [95]. Terpenes have a variety of roles in mediating antagonistic and beneficial interactions among organisms [96]. There are a lot of data in the literature describing the ability of specific microorganisms to perform microbial transformations of terpenes like Mucor sp. [97], Aspergillus niger cultures [98], etc. There are reviews on microbial transformation of monoterpenes [99] and triterpenes [100-102]. The microbial transformations of terpenoids applied in folk medicine and of interest for pharmacy are also reviewed in the literature like antimalarial ones [103,104], ent -kaurane diterpenes [105], Schisandraceae [106] and oleanane triterpenoids [107], taxanes [108], etc.

Here we will discuss microbial transformations of terpenes which afford compounds with improved biological activity.

Taxol is a naturally occurring diterpenoid widely applied as a powerful anti-cancer drug. More than 500 microorganisms were screened for their ability to achieve useful biotransformation of taxol/ cephalomannine and Streptomyces sp. MA 7065 was selected due to its ability for formation of hydroxy-derivatives with significantly enhanced characteristics against human tumor cell lines than the respective substrates [109].

Two taxadienes obtained from sinenxan A by chemical synthesis were transformed by filamentous fungi (Cunninghamella echinulata and Aspergillus niger ) and actinomycete strains (Streptomyces griseus and Nocardia purpurea ) into twenty one derivatives. Two of these derivatives (2α-hydroxy-5α,10β,14β-triacetoxytaxa-4(20),11(12)-diene and 2α,5α,10β,14β-tetraacetoxytaxa-4β,20-epoxy-11(12)-ene) are considered promising lead compounds for reversal agents against A549/taxol tumor MDR cells [110].

When subjected oleanoic acid to transformation with the filamentous fungus Fusarium lini , Choudhary et al. obtained two metabolites, one with a hydroxyl group at C2 and one with hydroxyl groups at C2 and C11. Both metabolites showed more potent inhibitory activities against the enzyme α-glucosidase than the clinically used drug acarbose and comparable activities with the standard drug deoxynojirimycin [111]. In 2013, Martinez et al. reported on the antitumor properties of the 30-hydroxyderivative of the oleanoic acid (queretaroic acid) derived from the transformation of the oleanoic with Rhizomucor miehei [112].

Cycloastragenol, which is the main aglycon of many cycloartanetype glycosides found in Astragalus genus, has been recently introduced to the dietary supplement market as TA-65®, a new generation anti-aging molecule. Subjected to transformation by Cunninghamella blakesleeana cycloastragenol gave a metabolite with an interesting triterpenic skeleton derived due to an exceptional transformation involving ring cleavage and methyl group migration [113].

Steviol is an aglycone of stevioside, the major sweet component isolated from leaves of Stevia rebaudiana (Bertoni) Bertoni (Compositae ). The group of de Olivera et al. performed continuous work for obtaining new derivatives of steviol. They functionalized rings B and C of isosteviol (a beyerane-type diterpenoid) by Fusarium verticilloides affording 7α-hydroxy- and 12β-hydroxy-derivatives [114]. The 7β-hydroxylation of isosteviol was achieved by Aspergillus niger and Rhizopus arrhizus , the 1α-hydroxylation by Aspergillus niger and the 17-hydroxylation by Penicillium chrysogenum [115].

Akihisa et al. also obtained 7β-hydroxyisosteviol from isosteviol by Aspergillus niger accompanied by 11β-hydroxyisosteviol and 12β- hydroxyisosteviol as well. The transformation of isosteviol by Glomerella cingulata afforded 17-hydroxyisosteviol and resulted in 7- oxoisosteviol when Mortierella elongate was employed. Importantly, all five hydroxylated metabolites exhibited more potent inhibitory effects on tumor promoters than parent diterpenes [116].

Mucor recurvatus was found to transform steviol-16α,17-epoxide into ent-13,16β,17-trihydroxykauran-19-oic acid, derivative with higher antihyperglycemic activity than steviol. Importantly, the amounts of the derivative were enough to provide a technical basis for studying its mechanism of action as well as its pharmacological and toxicological effects [117].

Aspergillus niger and Fusarium moniliforme are found capable of increasing polarity of Isodon and Rabdosia diterpenoids, known as antimicrobial and antitumor compounds, by hydroxylating nonactivated positions. The activity of the polyhydroxylated derivatives is dependent on the number and the position of hydroxyl groups in the molecule [118].

Ent -8(14),15-primaradien-19-ol (pimarane-type diterpene) was obtained by fungal transformation and showed very promising Ent -8(14),15-primaradien-19-ol (pimarane-type diterpene) was obtained by fungal transformation and showed very promising minimal inhibitory concentration value against the main microorganisms responsible for dental caries [119].

Diterpenes stemodin, stemodinone, stemarin are isolated from the shrub Stemodia maritime . All three compounds were transformed by Aspergillus niger ATCC 9142 and gave three hydroxylated compounds, two known analogues and one novel metabolite. Stemodione was hydroxylated to two known analogues while stemarin gave four new compounds [120]. When transformed by Phanerochaete chrysosporium three three-hydroxylated products of stemodin and one dihydroxylated product of stemodin were produced [121]. The transformation with Cunninghamella echinulata resulted in three three-hydroxylated products of stemodin: two dihydroxylated products of stemodinone, one of which new, and in one novel metabolite from stemarin as a sole metabolite [121]. Beauveria bassiana ATCC 7159 transformed stemodin and stemodinone exclusively into hydroxylated derivatives 2α,13,18-trihydroxystemodane and 13,18- dihydroxystemodan-2-one, respectively. Stemarin was converted to the novel 1β,13,19-trihydroxystemarane and 13-hydroxystemarane-19- carboxylic acid [122].

Jatrophone was transformed by Aspergillus niger ATCC 16404 and afforded the new diterpene 9β-hydroxyisabellinone which revealed strongly reduced cytotoxicity and enhanced selectivity assessed on a permanent human epithelial gastric cell line (AGS) (ATCC CRL-1739) [123].

The transformation of the imbricatoic acid by Aspergillus niger afforded a main compound identified as 1α-hydroxylabdan-19-oic acid. Rhizopus nigricans gave rise to 15-hydroxy-8,17-epoxyderivative. The main products obtained by transformation with Cunninghamella echinulata were identified as mycophenolic acid and its 3-hydroxy derivative. The last two compounds showed low toxicity towards human lung fibroblasts and AGS cells while the cytotoxicity of 1α- hydroxyimbricoic acid was a moderate one [124].

Microbial transformation of the two 8,9-unsaturated lactonic drimane derivatives confertifolin and isodrimenin (isolated from the bark of Drymus winteri Forst, Winteraceae , a South American tree commonly found in Chile and Argentina) with Mucor plumbeus , Aspergillus niger and Rhizopus arrhizus has been reported. It was shown that process easily provides 3β-hydroxyderivatives in high yield. In the case of incubation of isodrimenin with R. arrhizus , an additional product hydroxylated at C7 could be obtained. Such regio- and stereoselectively functionalized compounds are of interest because they often correspond to minor natural products usually isolated in very small amounts [125].

Limonoids, chemically classified as tetranortriterpenoids, have been found to possess anti-cancer, anti-malarial, anti-HIV, antimicrobial and several other pharmacological activities. Haldar et al. reported 12β- and 17β-hydroxylation on the basic limonoid skeleton using Mucor -mediated microbial transformation. 12β-hydroxy products are rare in nature and therefore this report is important providing way to production of 12β-hydroxy limonoids and further evaluation of their bioactivities [126].

Garcia-Granados et al. attempted microbial transformation of ent -13-epi -manoyl oxides - labdane-type diterpenoids - to introduce hydroxyl groups at positions difficult to achieve by chemical means as to produce new bioactive, highly hydroxylated analogues of ent - forscolin [127] which is naturally produced by the Indian plant Coleus forskohlii and is commonly used to raise levels of cyclic AMP in the study and research of cell physiology.

The maslinic acid was transformed by Cunninghamella blakesleeana . The obtained four new compounds (7β-hydroxy-, 15α- hydroxy-, 7β, 15α-dihydroxy- and 13β-hydroxy-derivatives) were more polar than the parent one [128]. The action of Rhizomucor miehei on the maslinic acid resulted in formation of five derivatives, an olean-11- en-28,13β-olide derivative, a metabolite hydroxylated at C30, an 11- oxo-derivtive and two metabolites with an 11α,12α-epoxy group, hydroxylated or not at C30 [112].

Licorice (Glycyrrhiza grabra ) has well known pharmacological properties [129]. When transformed by Cunninghamella blakesleeana , its active component, the glycyrrhetinic acid, affords six metabolites, two of them being major ones and revealing considerable activities against the drug-resistant Enterococcus faecalis [130].

Betulin (lupane-type triterpene obtained from the bark extract of white birch, Betula platyphylla Sukatshev var. japonica ) was transformed by Chaetomium longirostre into 4,28-dihydroxy-3,4-secolup- 20(29)-en-3-oic acid and 4-hydroxy-3,4-seco-lup-20(29)-ene-3,28- dioic acid. Betulonic acid, a chemical oxidation product of betulin, transformed by the same fungus gave rise to 4,7β,17-trihydroxy-3,4- seco-28-norlup-20(29)-en-3-oic acid and 7β,15α-dihydoxy-3- oxolup-20(29)-en-28-oic acid. All compounds (betulin, betulonic acid and their metabolites) showed potent inhibitory effects on tumor promotion. Biotransformation products that underwent ring-opening and hydroxylation exhibited more potent activity than their corresponding precursors [131].

Betulin was transformed also by Cunninghamella blakesleeana cells with formation of at least five products among which betulinic acid was the most important one due to its antiretroviral, antimalarial and anti-inflammatory properties. Recently, betulinic acid was described as potential anticancer agent as well. This transformation reaction provides an attractive alternative approach to chemical synthesis, because is less time-consuming and more environmentally friendly [132].

Gentiopicroside is a principal bitter substance found in many gentianaceous plants which are widely used as medicinal herbs in China and Europe due to the variety of pharmacological activities they exhibit. When transformed by the endophytic fungus Penicillium crustosum it gave several metabolites, three of them showing potent protective effects against HL-7702 cell injury induced by hydrogen peroxide in the in vitro bioassay, while the substrate exhibited no activity at the tested concentrations [133].

β-lapachone is an ortho-naphthoquinone found as a minor constituent in the heartwood of the Tabebuia species and considered as promising anticancer agent. It has been included in clinical trials as mono therapy and in combination with other cytotoxic drugs. β- lapachone and one of its derivatives obtained by microbial transformation with Cunninghamella elegans containing β-D-glucose moiety attached to position 6 of ring B were subjected to cell toxicity assays. Results displayed lower activity of the derivative against breast cancer line SKBR-3 in comparison with β-lapachone, but did not show cytotoxicity against normal fibroblasts cell line GM07492-A, whereas β-lapachone was highly toxic [134].

Microbial transformation of alkaloids

Alkaloids represent a diverse group of plant natural products with variable chemical structure. They are used for centuries because of the wide variety of their physiological effects [135]. The interactions of microorganisms with alkaloids are of special interest. The data on microbial transformations of alkaloids accumulated up to 2000-2001 were reviewed by Abraham and Spassov [136] while at the same time Rathborne and Bruce emphasized in their review paper on the engineering biocatalytic routes for production of semisynthetic opiate drugs [137]. Morphine and codeine were transformed into potent analgesic hydromorphone and the mild analgesic/antitussive hydrocodone, respectively, by recombinant E. coli [138]. Demethylations, oxidations and reductions of morphine alkaloids were performed with different fungal strains, Cunninghamella echinulata being the most effective one [139]. Rhizobium radiobacter was reported to hydroxylate codeine to its C-14 derivative. This transformation reaction is of importance for the production of drugs displaying analgesic, antitussive and narcotic antagonist characteristics like oxycodone [140].

Veratrum alkaloids are a group of potent hypotensive agents that lower blood pressure by reflex suppression of the cardiovascular system. Lü et al. reported biotransformation of vermitaline (verazine type steroidal alkaloid isolated from the roots of Veratrum dahuricum and one of the most extensively studied) by Cunninghamella echinulata into four metabolites, three of which being new compounds [141].

The steroidal alkaloid dictyophlebine (potent cholinesterase inhibitor) from the plant Sarcococca hookeriana BAILL was transformed by Rhizopus stolonifer into three polar derivatives, one of which revealed higher inhibitory activity than that of the parent compound [142].

The antimalarial property of cinchona bark and the subsequent isolation of its active compound, quinine, have played a pivotal medicinal role in human society for over 300 years [143]. The incubation of cinchona alkaloids with the endophytic Xylaria sp. isolated from Cinchona pubescens (Rubiaceae ) led to formation of three derivatives, quinine 1-N -oxide, quinidine 1-N -oxide and cinchonine 1-N -oxide, which revealed weakly inhibiting effect on the proliferation of the malaria pathogen Plasmodium falciparum , a chloroquine-resistant strain [144].

Ruscogenin is a steroidal glycoside extracted from ruscus roots. In Europe, the roots and stems of the Ruscus aculeatus (Butcher's Broom or thorny ruscus) have been used for centuries. Recent clinical observations reveal the vasculoprotective and phlebotonic properties of butcher's broom-based preparations. Ruscogenin is low water soluble which restricts its application, but a derivative with higher water solubility has been obtained via microbial transformation [145].

Microbial transformations of flavonoids

Flavonoids are plant metabolites with biological functions ranging from coloration of flowers as a visual signal that attracts pollinators and protection from ultraviolet radiation and phytopathogens to participation in stress responses [146]. According to Ren et al., flavonoids are a group of more than 4000 polyphenolic compounds which possess a common phenylbenzopyrone structure (C6-C3-C6) and are categorized according to the saturation level and opening of the central pyran ring [147]. The microbial transformation strategies for production of flavonoids have attracted considerable interest because they allow yielding of novel flavonoids, which do not exist in the nature [148]. The achievement of microbial glycosylation led to significant advance in biotechnological glycosylation of flavonoids [149]. The main function of glycosylation processes are stabilization, detoxification and solubilization of substrates [150]. The substituent groups in flavonoids affect their properties. Thus, the hydroxyl groups are both important for the antioxidizing capacity and key points for further modification like O -methylation and C-glycosilation. The O - methylation of flavonoids changes chemical reactivity of the phenolic hydroxyl groups and increases lipophilic properties of the compound which is significant for retaining optimal hydrophilic- lipophilic properties of newly formed flavones [151].

The biological activities of baicalin and baicalein (isolated from Radix Scutellariae) among which antiallergic, anti-inflammatory, antitrombotic, and anticancerogenic might be changed and/or improved by microbial transformation. Thus, baicalin can afford 4', 5,6,7-tetrahydroxyflavone by Coryneum betulinum , Chaetomium sp. and Cryptosporiopsis radicicola. Chaetomium sp. transforms baicalin also into 5,7-dihydroxy-6-methoxyflavone while Penicillium chrysogenum gives rise to 5,7-dihydroxy-4',6-dimethoxyflavone. Both reactions, methylation and hydroxylation, proceed with high regionspecificity [152].

Puerarin is an isoflavone from Pueraria lobata with promising biological activities but limited clinic use due to its low water solubility and poor adsorption after oral administration. It was transformed by Lysinibacillus fusiformis into puerarin-7-O -fructosid which revealed an increased antioxidant activity combined with improved water solubility [153].

Quercetin is a natural flavonoid distributed in many plants such as green tea, fruits and leaf vegetables. It has displayed a variety of biological activities including anticancer, antihypertensive, antiinflammatory and antiviral properties [154]. The metabolism of quercetin which involves C-3 glucosylation, C-3' O -methylation, and a dehydrogenation was studied by Cunninghamella elegans ATCC 9245 thus expanding knowledge on the catalytic repertoire of this filamentous fungus [155]. Recently, a note regarding efficient bioconversion of quercetin into a novel glycoside (quercetin-7 O -β-4″- deoxy-hex-4″-enopyranosiduronic acid) by Streptomyces rimosus subsp. Rimosus ATCC 10970 was published [154]. This is the strain producing the well-known antibiotic oxytetracycline and the polyene antifungal antibiotic rimocidin. Derivatives of rutin (quercetin 8-Cglucoside) are used to increase capillary resistance and are recommended for treatment of circulatory disorders and inflammation [156]. Reported were promising anticancer activities as well as important antioxidant, radical scavenger, antileukemic, vasodilator activities of flavonoids [147,157].

Two of the derivatives of flavones biotransformation by Aspergillus niger (2'-hydroxydihydrochalcone and 2'-hydroxyphenylmethylketone) revealed higher antioxidant activity than the substrate as well as antimicrobial activity against Pseudomonas aeruginosa , Aspergillus flavus and Candida albicans [158].

Mucor species were found to perform reactions of deglycosilation, dehydrogenation and O -methylation of the flavonoid naringin (compound giving grapefruit its typical bitter flavor and being reported to exhibit a number of biological activities) resulting in formation of eleven products [159]. Trichoderma harzianum was capable of naringin hydroxylation affording 3'-hydroxyl naringin and 3'5'-dihyroxyl naringin which revealed 68.6- and 77.9-fold increase in the antioxidant activity, compared to the parent compound [160].

Microbial transformation of (poly)phenols

Natural (poly)phenols are known with their wide range of pharmacological activities and with their applicability as food additives. In the recent years the useful properties of some of the (poly)phenols like resveratrol and curcumin were improved by microbial transformations.

Resveratrol (3,5,4'-trihydroxystilbene) is one of the most widely studied polyphenols produced by plants and presented in red wine. Microbial transformation of trans -resveratrol into piceatannol by a wild type Streptomyces sp. was reported and the obtained piceatannol was found to have antioxidative effects and to exhibit potential anticancer properties as suggested by its ability to suppress proliferation of a wide variety of tumor cells, including leukemia, lymphoma, and cancers of the breast, prostate, colon, melanoma and apoptosis in colorectal cancer [161]. Resveratrol was transformed by Geotrichum histeridarum in bis -resveratrol which revealed 1.7 fold increased activity than parent substrate [162]. The preparative scale microbial transformation of resveratrol by Bacillus cereus resulted in formation of piceid [163]. Piceid is the main component of the Polygonum cupsidatum roots, used in Japanese and Chinese folk medicine for the treatment of some cardiac ailments, including atherosclerosis and inflammation [164].

The polyphenolic compound curcumin has shown a wide range of pharmacological activities and has been widely used as a food additive. However, the clinical use of curcumin is limited to some extent because of its poor water solubility and low bioavailability. To overcome these problems, many approaches have been attempted and structural modification of curcumin and microbial transformation has been proven to be alternative. The transformation of curcumin into its analogue was carried out by the endophytic fungus CL-Bel-5F isolated from Curcuma longa L. Studies on the anticancer and hepatoprotective activities of the hexahydrocurcumin are in progress [165]. Microbial transformation of curcumin into four colorless hydroderivative by the endophytyc fungus Diaporthe sp. associated with Curcuma longa was reported [166]. The newly isolated yeast strain Pichia kudriavzevii was found to transform curcumin into hexa- and tetrahydrocurcumin [167].

Alternative medicine and microbial transformations of its active ingredients

Throughout Old Europe, Asia, Middle East, Africa, and the Americas, early people were making and consuming fermented drinks with an amazing variety of plant substances that were indigenous to their area [168]. The therapeutic advantages of medicinal herbs fermented with Lactobacillus plantarumi in topical application and its activities on atopic dermatitis were shown [169]. The Taiwanese alternative medicine Lu-Doh-Huang was further developed with an application of pyrosequencing and culture methods to assess the microbial diversity of fermented mung beans [170]. Changes in the gingenoside content [171] and preparation of minor gingenosides [172] were achieved via controlled fermentation processes. In the recent years, with advances in microbial fermentation and transformation, the traditional Chinese medicine has become a new way to produce new drugs and get active compounds [11].

The tetracyclic alkaloids tetrahydroprotoberberines (THPBs) are isolated from Chinese herbs due to their unique pharmacological profile as D2 dopamine receptor antagonists and D1 receptor agonists [173]. The ability of the fungal strain Gliocladium deliquescens NRRL1086 for regio- and enantio-selective glycosilation of a series of THPBs is very attractive as glycosidic THPBs are very rare in the nature. This finding could provide pure THPB derivatives for bioassays and more important, prove to be an alternative method for their preparation [174].

The enantiomeric lycodane alkaloid Huperzine A (Hup A) isolated from the club moss, Huperzia serrata (Thunb.), Huperziaceae is known in China as Qian Ceng Ta and has been marketed there as a new drug for Alzheimer’s disease treatment. Its derivative ZT-1 is being developed as anti- Alzheimer’s disease new drug candidate both in China and in Europe [175]. The product M3, obtained via transformation of HupA by Streptomyces griseus after a two-step procedure and various chromatographic techniques, was identified as Huperzine A 8α,15α-epoxide [176] and found to protects PC12 cells against sodium nitroprusside-induced apoptosis [177]. Recently, Huperzine A was transformed by the fungal endophyte Ceriporia lacerate into several derivatives, some of them comprising tremulane sesquiterpenoids-Huperzine A hybrids [178].

Gingenosides are the main chemical constituents of Chinese ginseng (Panax ginseng C.A. Mey, Araliaceae ), they exhibit extensive biological activities and are responsible for the tonic functions of ginseng. 20(S)-protopanaxadiol and its analogues 20(S)- protopanaxatriol are aglycones of gingenosides. Transformation of 20(S)-protopanaxadiol by Mucor spinosus resulted in formation of eight derivatives, six of them being new compounds. The 12β-hydroxyl group of all products was specifically dehydrogenated into carbonyl group while some of the products were hydroxylated at novel positions [120]. The 20(S)-protopanaxadiol was transformed also by Absidia corymbifera and three of the five derivatives were found to be more potent inhibitors against DU-145 and PC-3 cell lines than the substrate [179]. It was suggested the regulation of the external calcium concentration to be used for manipulation of the gingenoside Rb1 transformation into gingenoside Rd by Paecilomyces bainier [180].

Methyl protodioscin is among the active compounds isolated from the rhizome of Dioscorea collettii var. hypoglauca (Dioscoreaceae ), a Chinese herbal remedy for the treatment of carcinomas for centuries. It was transformed by Penicillium melinii into seven derivatives, most of them revealing considerable cytotoxic activities against HepG2, NCIH460, MCF-7 and HeLa cell lines [181].

Closing Remarks

Microbial transformations of organic compounds gained their importance with the development of steroid drugs where such processes take an irreplaceable role. Although the application of microorganisms for carrying out chemical reactions was invented four decades before the term Green Chemistry to be officially coined, it remains one of the outstanding applications of Green Chemistry within the pharmaceutical industry [182]. Since then a great variety of plant derived biologically active compounds were subjected to microbial transformations aiming at improvement of their biological activity and administration. Microbial transformations performed by fungal strains are of immense importance as models of mammalian metabolism of the plant origin compounds which are applied in medicine. They give information regarding correlations between structures of the compounds of interest and their specific biological activities simultaneously. Investigations on microbial transformations give an insight in both, chemical diversity of plant derived biologically active compounds and their derivatives and diversity of microorganisms. From this point of view any single report on specific microbial transformation of some biologically active compound performed by some microorganism is of interest.

References

  1. Sarker SD, Latif Z, Gray AI (2006) Natural Products Isolation(2nd edn.) (Methods in Biotechnology, Vol. 20). Journal of Natural Products 70: 712.
  2. Handa SS, Khanuja SPS, Longo G, Rakesh DD (2008) Extraction technologies for medicinal and aromatic plants, ICS-UNIDO International Centre for Science and High Technology, Trieste, Italy.
  3. Bucar F, Wube A, Schmid M (2013) Natural product isolation--how to get from biological material to pure compounds.Nat Prod Rep 30: 525-545.
  4. Neda PV, Pop RO, Sfarloaga P, Grozescu I, Segneanu AE (2012) Peptide and amino acids separation and identification from natural products, Analytical Chemistry, I. S. Krull (ed.) InTech.
  5. Salas CE, Badillo-Corona JA, Ramírez-Sotelo G, Oliver-Salvador C (2015) Biologically active and antimicrobial peptides from plants.Biomed Res Int 2015: 102129.
  6. Venisetty RK, Ciddi V (2003) Application of microbial biotransformation for the new drug discovery using natural drugs as substrates.Curr Pharm Biotechnol 4: 153-167.
  7. Alfarra HY, Omar MN (2013) Microbial transformation of natural products. Greener J Biol Sci 3: 357-364.
  8. Gao F, Zhang JM, Wang ZG, Peng W, Hu HL, et al. (2013) Biotransformation, a promising technology for anti-cancer drug development.Asian Pac J Cancer Prev 14: 5599-5608.
  9. Hegazy ME, Mohamed TA, ElShamy AI, Mohamed AE, Mahalel UA, et al. (2015) Microbial biotransformation as a tool for drug development based on natural products from mevalonic acid pathway: A review.J Adv Res 6: 17-33.
  10. Baiping M, Bing F, Hongzhi H, Yuwen C (2010) Biotransformation of Chinese herbs and their ingredients. Modernization of traditional Chinese medicine and materia medica 12: 150-154
  11. Hwang D, Chelen Z, Jinping HE, Xiaobao Y (2014) Analysis of traditional Chinese medicine based on microbial fermentation and transformation. International Journal of Medical Advances and Discovery 1: 7-12
  12. Kieslich K (1984) Biotechnology. A Comprehensive treatise in 8 volumes. Rehm H-J and Reed G. (eds.) Biotransformation 6: 1.
  13. Lilly MD (1984) Advances in biotransformation processes. Trans Inst Chem Eng 72: 27-34.
  14. Fernandes P, Cruz A, Angelova B, Pinheiro HM, Cabral JMS (2003) Microbial conversion of steroid compounds: recent developments. Enzyme Microb Tech 32: 688-705
  15. Fernandes P, Cabral JMS (2010) Steroid bioconversions, in: Encyclopedia of Industrial Biotechnology - Bioprocess, Bioseparation, and Cell Technology, M. Flickinger (ed.) 7: 4610-4628.
  16. Akhrem and Titov (1971) Steroids and Microorganisms, “Nauka”, Moscow (in Russian).
  17. Skryabin GK, Golovleva LA (1976) Microorganisms in organic chemistry. “Nauka”, Moscow (in Russian).
  18. Mahato SB, Majumdar I (1993) Current trends in microbial steroid biotransformation.Phytochemistry 34: 883-898.
  19. Mahato SB, Garai S (1997) Advances in microbial steroid biotransformation.Steroids 62: 332-345.
  20. Voishvillo NE, Turuta AM, Kamernitsky AV (1994) Microorganisms as reagents for transformation of 5a-steroids. Russ Chem Bull 43: 515-537.
  21. Donova MV (2007) [Transformation of steroids by actinobacteria: a review].Prikl Biokhim Mikrobiol 43: 5-18.
  22. Donova MV, Egorova OV, Nikolayeva VM (2005) Steroid 17ß-reduction by microorganisms – a review. Process Biochem 40: 2253-2262
  23. Borges KB, Gorges WS, Durán-Patrón R, Pupo MT, Bonato PS, et al. (2009) Stereoselective biotransformations using fungi as biocatalysts. Tetrahedron: Asymmetry 20: 385-397
  24. Bhatti HN, Khera RA (2012) Biological transformations of steroidal compounds: a review.Steroids 77: 1267-1290.
  25. Dykstra CM, Giles HD, Banerjee S, Pavlostathis SG (2014) Biotransformation of phytosterols under aerobic conditions.Water Res 58: 71-81.
  26. Murray HC, Peterson DH (1952) Oxygenation of steroids by Mucorales Fungi. US Patent 2: 602-769.
  27. Hogg JA (1992) Steroids, the steroid community, and Upjohn in perspective: a profile of innovation.Steroids 57: 593-616.
  28. Hirschmann R (1992) The cortisone era: aspects of its impact. Some contributions of the Merck Laboratories.Steroids 57: 579-592.
  29. Herzog H, Oliveto EP (1992) A history of significant steroid discoveries and developments originating at the Schering Corporation (USA) since 1948.Steroids 57: 617-623.
  30. Colton FB (1992) Steroids and "the pill": early steroid research at Searle.Steroids 57: 624-630.
  31. Fried J (1992) Hunt for an economical synthesis of cortisol: discovery of the fluorosteroids at Squibb (a personal account).Steroids 57: 384-391.
  32. Djerassi C (1992) Steroids and “the Pill”: early steroid research at Searle. Steroids 57: 631-634.
  33. Lütjohann D (2005) Cholesterol metabolism in the brain: importance of 24S-hydroxylation. In: Trends in cholesterol research by M.A. Kramer (ed.) Nova Biomedical Books, New York, pp: 75-95.
  34. Liljestrand C (1950) Nobel Prize in Medicine and Physiology Award Ceremony Speech.
  35. Renneberg R (2008) Mexico, the father of the pill and the race for cortisone.Biotechnol J 3: 449-451.
  36. Quirke V (2005) Making British cortisone: Glaxo and the development of corticosteroids in Britain in the 1950s-1960s.Stud Hist Philos Biol Biomed Sci 36: 645-674.
  37. Maxon W (1985) Steroid bioconversions: one industrial perspective. Annual Reports on fermentation Processes 8: 171-185.
  38. Kieslich K (1985) Microbial side-chain degradation of sterols.J Basic Microbiol 25: 461-474.
  39. Szentirmai A (1990) Microbial physiology of sidechain degradation of sterols. J Ind Microbiol 6: 101-115.
  40. Amin HAS, Abd El-Hadi A, Mohamed SS (2010) Immobilization of Mycobacterium sp. NRRL B-3805 cells onto radiation crosslinked PVA/PVP hydrogels for production of androstenones from ß-Sitosterol. Aust J Basic Appl Sci 4: 2196-2205
  41. Claudino MJ, Soares D, Van Keulen F, Marques MP, Cabral JM, et al. (2008) Immobilization of mycobacterial cells onto silicone--assessing the feasibility of the immobilized biocatalyst in the production of androstenedione from sitosterol.Bioresour Technol 99: 2304-2311.
  42. Llanes N, Fernandes P, Leon R, Cabral JMS, Pinheiro HM (2001) Conversion of ß-sitosterol by Mycobacterium sp. NRRL B-3805 cells immobilized on Celite supports. J Mol Catal B: Enzym 11:523-530
  43. Kutney J, Milanova RK, Vassilev CD, Stefanov SS, Nedelcheva NV (2000). Process for the microbial conversion of phytosterols to androstenedione and androstadienedione, US Patent.
  44. Cruz A, Angelova B, Fernandes P, Cabral JMS, Pinheiro HM (2004) Study of key operational parameters for the side-chain cleavage of sitosterol by free mycobacterial cells in bis-(2-ethylhexyl) phthalate. Biocatal Biotransfor 22: 189-194.
  45. Angelova B, Fernandes P, Spasova D, Mutafov S, Pinheiro HM, et al. (2006) Scanning electron microscopy investigations on bis(2-ethylhexyl)phthalate treated Mycobacterium cells.Microsc Res Tech 69: 613-617.
  46. Pendharkar GB, Patil S, Anjum SD (2014) Enhanced biotransformation of phytosterols, a byproduct of soybean refineries, to a key intermediate used for synthesis of steroidal drugs. Asian J Pharm Clin Res 7:178-180.
  47. Malaviya A, Gomes J (2008) Nutrient broth/PEG200/TritonX114/Tween80/Chloroform microemulsion as a reservoir of solubilized sitosterol for biotransformation to androstenedione.J Ind Microbiol Biotechnol 35: 1435-1440.
  48. Carvalho F, Marques MP, de Carvalho CC, Cabral JM, Fernandes P (2009) Sitosterol bioconversion with resting cells in liquid polymer based systems.Bioresour Technol 100: 4050-4053.
  49. Cruz A, Fernandes P, Cabral JMS, Pinheiro HM (2001) Whole-cell bioconversion of ß-sitosterol in aqueous-organic two-phase systems. J Mol Catal B-Enzym 11: 579-585
  50. Marques MPC, Carvalho F, Magalhães S, Cabral JMS, Fernandes P (2009) Screening for suitable solvents as substrate carriers for the microbial side-chain cleavage of sitosterol using microtitre plates. Process Biochem 44:556-561.
  51. Phase N, Patil S (1994) Natural oils are better than organic solvents for the conversion of soybean sterols to 17-ketosteroids by Mycobacterium fortuitum.World J Microbiol Biotechnol 10: 228-229.
  52. Kutney JP, Herrington EJ, Spassov G (2011) Process for fermentation of phytosterols to androstadienedione. Patent EP 1507867 B1.
  53. Stefanov S, Yankov D, Beschkov V (2006) Biotransformation of phytosterols to androstenedione in two phase water–oil systems. Chem Biochem Eng Q 20: 421-427.
  54. Marques MPC, Carvalho F, de Carvalho CCCR, Cabral JMS, Fernandes P (2010) Steroid bioconversion: Towards green processes. Food Bioprod Process 88:12-20.
  55. Andriushina VA, Druzhinina AV, Iaderets VV, Stytsenko TS, VoÄ­shvillo NE (2011) [Hydroxylation of steroids by Curvalaria lunata mycelium in the presence of methyl-beta-cyclodextrine].Prikl Biokhim Mikrobiol 47: 50-57.
  56. Wang W, Yu L (2011) Preparation, characterization, and biotransformation of the inclusion complex of phytosterols and hydroxypropyl-beta-cyclodextrin by Mycobacterium neoaurum.Z Naturforsch C 66: 277-282.
  57. Shen Y, Wang M, Zhang L, Ma Y, Ma B, et al. (2011) Effects of hydroxypropyl-β-cyclodextrin on cell growth, activity, and integrity of steroid-transforming Arthrobacter simplex and Mycobacterium sp.Appl Microbiol Biotechnol 90: 1995-2003.
  58. Zhang XY, Peng Y, Su ZR, Chen QH, Ruan H, et al. (2013) Optimization of biotransformation from phytosterol to androstenedione by a mutant Mycobacterium neoaurum ZJUVN-08.J Zhejiang Univ Sci B 14: 132-143.
  59. Shao M, Zhang X, Rao Z, Xu M, Yang T, et al. (2015) Enhanced Production of Androst-1,4-Diene-3,17-Dione by Mycobacterium neoaurum JC-12 Using Three-Stage Fermentation Strategy.PLoS One 10: e0137658.
  60. Wang ZL, Zhao FS, Chen DJ, Li DT (2006) Biotransformation of phytosterol to produce androsta-diene-dione by resting cells of Mycobacterium in cloud point system. Process Biochem 41: 557–561.
  61. Hillier SG (2007) Diamonds are forever: the cortisone legacy.J Endocrinol 195: 1-6.
  62. Datcheva VK, Voishvillo NE, Kamernitskii AV, Vlahov RJ, Reshetova IG (1989) Synthesis of 9 alpha-hydroxysteroids by a Rhodococcus sp.Steroids 54: 271-286.
  63. Angelova B, Mutafov S, Avramova T, Stefanova L (2005) Effect of nitrogen source in cultivation medium on the 9a-hydroxylation of pregnane steroids by resting Rhodococcus sp. cells. Biotechnol Biotec Eq 19: 113-116.
  64. Petrusma M, van der Geise R, Dijkhuizen L (2014) 3-Ketosteroid 9a-hydroxylase enzymes: Rieske non-cheme monooxygenases essential for bacterial steroid degradation. Antonie van Leeuwenhoek 106:157-172.
  65. Donova MV, Gulevskaya SA, Dovbnya DV, Puntus IF (2005) Mycobacterium sp. mutant strain producing 9alpha-hydroxyandrostenedione from sitosterol.Appl Microbiol Biotechnol 67: 671-678.
  66. Wei W, Fan SY, Wang FQ, Wei DZ (2014) Accumulation of androstadiene-dione by overexpression of heterologous 3-ketosteroid Δ1-dehydrogenase in Mycobacterium neoaurum NwIB-01.World J Microbiol Biotechnol 30: 1947-1954.
  67. Mutafov S, Angelova B, Avramova T, Boyafjieva L, Dimova I (1997) The indicibility of 9a-steroid hydroxylating activity in resting Rhodococcus sp. cells. Process Biochem 32:585-589.
  68. Avramova T, Spassova D, Mutafov S, Momchilova S, Boyadjieva L, et al. (2010) Effect of Tween 80 on 9a-steroid hydroxylating activity and ultrastructural characteristics of Rhodococcus sp. cells. World J Microb Biot 26: 1009-1014.
  69. Angelova B, Fernandes P, Cruz A, Pinheiro HM, Mutafov S, et al. (2005) Hydroxylation of androstenedione by resting Rhodococcus sp. cells in organic media. Enzyme Microb Tech 37: 718-722.
  70. Bolten SL, Clayton RA, Easton AM, Engel LC, Messing DM, et al. (2007) Aspergillus ochraceus 11a-hydroxylase and oxidoreductase. Patent US 7238507 B2.
  71. Nassiri-Koopaei N, Faramarzi MA (2015) Recent developments in the fungal transformation of steroids. Biocatal Biotransfor 33:1-28.
  72. Sukhodolskaya GV, Chincholkar S, Baklashova TG, Angelova BA, Koshcheenko KA (1989) Physiological - biochemical features of immobilized Curvularia lunata BKM F-644 mycelium with steroid-11ß-hydroxylase activity. Proc Internat Symp "Physiology of Immobilized Cells", Wageningen, The Netherlands, pp: 591-595.
  73. Manosroi J, Chisti Y, Manosroi A (2006) Biotransformation of cortexolone to hydrocortisone by molds using a rapid color development assay.Prikl Biokhim Mikrobiol 42: 547-551.
  74. Lu W, Du L, Wang M, Jia X, Wen J, et al. (2006) Effect of two-steps substrate addition on steroids 11ß-hydroxylation by Curvularia lunata CL-114. Biochem Eng J 32:233-238.
  75. Lu W, Du L, Wang M, Guo Y, Lu F, et al. (2007) A novel substrate addition method in the 11ß-Hydroxylation of Steroids by Curvularia lunata. Trans IChemE, Food and Bioproducts Processing 85:63-72.
  76. Allam RF, Shafei MS, El-Refai AElMH, Ali MI, Khattab AElNA, et al. (2012) 11 ß-Hydroxylation of cortexolone using immobilized Cunninghamella elegans protoplasts. Afr J Biotechnol 11: 10775-10784
  77. Mohamed SS, Shafei MS, Allam RF, Elazzazy AM, Elsoud MMA, et al. (2013) Effect of aeration rate on the biotransformation of cortexolone using Cunninghamella elegans in a laboratory scale bioreactor. World Appl Sci J 25:176-183
  78. Sonomoto K, Hoq MM, Tanaka A, Fukui S (1983) 11beta-Hydroxylation of Cortexolone (Reichstein Compound S) to Hydrocortisone by Curvularia lunata Entrapped in Photo-Cross-Linked Resin Gels.Appl Environ Microbiol 45: 436-443.
  79. Houng JY, Chiang WP, Chen KC, Tiu C (1994) 11a -Hydroxylation of progesterone in biphasic media using alginate-entrapped Aspergillus ochraceus gel beads coated with polyurea. Enzyme Microb Tech 16: 485-491
  80. Kulkarni AG, Lele SS, Kulkarni PR (1998) Improved adsorption of Aspergillus niger 589 spores on high-density polyethylene for progesterone biotransformation. J Ferment Bioeng 86: 510-512.
  81. Wang J, Chen C, Li B, Zhang J, Yu Y (1998) Production of hydrocortisone from cortexolone-21-acetate by immobilized Absidia orchidis in cosolvent-containing media. Enzyme Microb Tech 22: 368-373
  82. Ahmed EM (2007) Production of 11a-hydroxyprogesterone using Aspergillus terreus immobilized on polytetrafluoroethylene. Braz J Microbiol 38: 224-229.
  83. Iaderets VV, Andriushina VA, Bartoshevich IuE, Domracheva AG, Novak MI, et al. (2007) [A study of steroid hydroxylation activity of Curvularia lunata mycelium].Prikl Biokhim Mikrobiol 43: 695-700.
  84. Žnidaršic-Plazl P, Plazl I (2010) Development of a continuous steroid biotransformation process and product extraction within microchannel system. Catal Today 157: 315-320
  85. Chen K, Tong W-Y, Wei D-Z, Jiang W (2007) The 11ß-hydroxylation of 16,17 a-epoxyprogesterone and the purification of the 11ß -hydroxylase from Absidia coerulea IBL02. Enzyme Microb Tech 41: 71-79.
  86. Sukhodolskaya GV, Angelova BA, Koschcheenko KA, Basovskaya IM, Skryabin GK (1993) RF Patent 1411336.
  87. Nobile A, Charney W, Perlman PL, Herzog HL Payne CC et al. (1955) Microbial transformation of steroids. I. ?1,4-diene-3-ketosteroids. J Am Chem Soc 77: 4184
  88. Perlman D, Titus E, Fried J (1952) Microbiological hydroxylation of progesterone. J Am Chem Soc 64: 2126-2126.
  89. Bernstein S (1992) Historic reflection on steroids: Lederle and personal aspects.Steroids 57: 392-402.
  90. Thoma RW, Fried J, Bonnano S, Grabowich P (1957) Oxidation of steroids by microorganisms. IV. 16a-hydroxylation of 9a-fluorohydrocortisone and 9a-fluoroprednisolone by Streptomyces roseochromogenus. J Am Chem Soc 79: 4818-4818
  91. Yamashita H, Shibata K, Yamakoshi N, Kurosawa Y, Mori H (1976) Microbial 16ß-hydroxylation of steroids with Aspergillus niger. Agric Biol Chem 40: 505-509
  92. Berrie JR, Williams RAD, Smith KE (1999) Microbial transformation of steroids – XI. Progesterone transformation by Streptomyces roseochromogenes – purification and characterization of the 16a-hydroxylase system. J Steroid Biochem 71: 153-165
  93. Bracco P, Janssen DB, Schallmey A (2013) Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450.Microb Cell Fact 12: 95.
  94. Fried J (1958) 9a-Halosteroids of the pregnane series and process therefor. US Patent 2852511.
  95. Tholl D (2006) Terpene synthases and the regulation, diversity and biological roles of terpene metabolism.Curr Opin Plant Biol 9: 297-304.
  96. Gershenzon J, Dudareva N (2007) The function of terpene natural products in the natural world.Nat Chem Biol 3: 408-414.
  97. De Olivera Silva E, Furtado NAJC, Aleu J, Collado IG (2013) Terpenoid biotransformations by Mucor species. Phytochem Rev 12: 857-876
  98. Parshikov IA, Sutherland JB (2014) The use of Aspergillus niger cultures for biotransformation of terpenoids. Process Biochem 49:2086-2100.
  99. Marmulla R, Harder J (2014) Microbial monoterpene transformations-a review.Front Microbiol 5: 346.
  100. Parra A, Rivas F, Garcia-Granados A, Martinez A (2009) Microbial transformation of triterpenoids. Mini Rev Org Chem 6:307-320
  101. Muffler K, Leipold D, Scheller M-C, Haas C, Steingroewer J, et al. (2011) Biotransformation of triterpenes. Process Biochem 46:1-15
  102. Shah SA, Tan HL, Sultan S, Faridz MA, Shah MA, et al. (2014) Microbial-catalyzed biotransformation of multifunctional triterpenoids derived from phytonutrients.Int J Mol Sci 15: 12027-12060.
  103. Parshikov IA, Netrusov A, Sutherland JB (2012) Microbial transformation of antimalarial terpenoids.Biotechnol Adv 30: 1516-1523.
  104. Omar MN, Khan NT, Hasali NHM, Moin SF, Alfarra HY (2012) Microbial transformation of artemisinin – anti- malaria drug. Adv Biores 3:27-31.
  105. Takahashi JA, Gomes DC, Lyra FH, dos Santos GF, Martins LR (2014) The remarkable structural diversity achieved in ent-kaurane diterpenes by fungal biotransformations. Molecules 19: 1856-1886
  106. Xia YG, Yang BY, Kuang HX (2015) Schisandraceae triterpenoids: a review. Phytochem Rev 14: 155-187
  107. Parikh NR, Mandal A, Bhatia D, Siveen KS, Sethi G, et al. (2014) Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.Phytochem Rev 13: 793-810.
  108. Feng X, Zou ZM, Chu ZY, Sun DA (2011) Biotransformation of Taxanes. Chinese Journal of Natural Medicines 9: 466–472
  109. Chen TS, Li X, Bollag D, Liu Y-c, Chang C-j (2001) Biotransformation of taxol. Tetrahedron Letters 42: 3787-3789
  110. Liu X, Chen R, Xie D, Mei M, Zou J, et al. (2012) Microbial transformations of taxadiens and the multi-drug resistant tumor reversal activities of the metabolites. Tetrahedron 68:9539-9549
  111. Choudhary MI, Batool I, Khan SN, Sultana N, Shah SA, et al. (2008) Microbial transformation of oleanolic acid by Fusarium lini and alpha-glucosidase inhibitory activity of its transformed products.Nat Prod Res 22: 489-494.
  112. Martinez A, Rivas F, Perojil A, Parra A, Garcia-Granados A, et al. (2013) Biotransformation of oleanolic and maslinic acids by Rhizomucor miehei.Phytochemistry 94: 229-237.
  113. Kuban M, Ongen G, Bedir E (2010) Biotransformation of cycloastragenol by Cunninghamella blakesleeana NRRL 1369 resulting in a novel framework.Org Lett 12: 4252-4255.
  114. De Olivera RH, Strapasson R (1996) Biotransformation of isosteviol by Fusarium verticilloides. Phytochemistry 43: 393-395.
  115. De Olivera BH, dos Santos MC, Leal PC (1999) Biotransformation of the diterpenoid, isosteviol, by Aspergillus niger, Penicillium chrysogenum and Rhizopus arrhizus. Phytochemistry 51: 737-741
  116. Akihisa T, Hamasaki Y, Tokuda H, Ukiya M, Kimura Y, et al. (2004) Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products.J Nat Prod 67: 407-410.
  117. Yang L, Qu R, Dai J, Chen X (2007) Specific methylation and epoxidation of sinexan A by Mucor genevensis and the multi-drug resistant tumor reversal activities of the metabolites. J Mol Catal B-Enzym 46: 8-13
  118. De Olivera BH, Fihlo JDS, Leal PC (2005) Biotransformation of steviol by Aspergillus niger and Fusarium moniliforme. J Braz Chem Soc 16: 210-213.
  119. Severiano ME, Simao MR, Porto TS, Martins CHG, Veneziani RCS, et al. (2010) Anticariogenic properties of ent-pimarane diterpenes obtained by microbial transformation. Molecules 15: 8553-8566
  120. Chen G, Yang M, Nong S, Yang X, Ling Y, et al. (2013) Microbial transformation of 20(S)-protopanaxadiol by Absidia corymbifera. Cytotoxic activity of the metabolites against human prostate cancer cells.Fitoterapia 84: 6-10.
  121. Lamm AS, Reynolds WF, Reese PB (2006) Bioconversion of Stemodia maritime diterpenes and derivatives by Cunninghamella echinulata var. elegans and Phanerochaete chrysosporium. Phytochemistry 67:1088-1093
  122. Buchanan GO, Reese PB (2001) Biotransformation of diterpenes and diterpene derivatives by Beauveria bassiana ATCC 7159.Phytochemistry 56: 141-151.
  123. Pertino M, Schmeda-Hirschmann G, Santos LS, Rodriguez JA, Theoduloz C (2007) Biotransformation of jatrophone by Aspergillus niger ATCC 16404. Z. Naturforsch 62b:275-289.
  124. Schmeda-Hirschmann G, Aranda C, Kurina M, Rodríguez JA, Theoduloz C (2007) Biotransformations of imbricatolic acid by Aspergillus niger and Rhizopus nigricans cultures.Molecules 12: 1092-1100.
  125. Maurs M, Azerad R, Cortés M, Aranda G, Delahaye MB, et al. (1999) Microbial hydroxylation of natural drimenic lactones.Phytochemistry 52: 291-296.
  126. Haldar S, Kolet SP, Thulasiram HV (2013) Biocatalysis: fungi mediated novel and selective 12ß- or 17ß-hydroxylation on the basic limonoid skeleton. Green Chem 15: 1311-1317.
  127. García-Granados A, Fernández A, Gutiérrez MC, Martínez A, Quirós R, et al. (2004) Biotransformation of ent-13-epi-manoyl oxides difunctionalized at C-3 and C-12 by filamentous fungi.Phytochemistry 65: 107-115.
  128. Feng X, Luan J, Guo F, Li D, Chu Z (2012) Microbial transformation of maslinic acid by Cunninghamella blakesleana. J Mol Catal B-Enzym 82: 127-130
  129. Davis EA, Morris DJ (1991) Medicinal uses of licorice through the millennia: the good and plenty of it.Mol Cell Endocrinol 78: 1-6.
  130. Qin YJ, Bing F, Song XB, Zhou WB, Yu HS, et al. (2010) Biotransformation of glycyrrhetinic acid by Cunninghamella blakesleeana. Chin J Nat Med 8:373-381.
  131. Akihisa T, Takamine Y, Yoshizumi K, Tokuda H, Kimura Y, et al. (2002) Microbial transformations of two lupane-type triterpenes and anti-tumor-promoting effects of the transformation products.J Nat Prod 65: 278-282.
  132. Feng Y, Li M, Liu J, Xu TY, Fang RS, et al. (2013) A novel one-step microbial transformation of betulin to betulinic acid catalysed by Cunninghamella blakesleeana.Food Chem 136: 73-79.
  133. Zeng WL, Li WK, Han H, Tao YY, Yang L, et al. (2014) Microbial biotransformation of gentiopicroside by the endophytic fungus Penicillium crustosum 2T01Y01.Appl Environ Microbiol 80: 184-192.
  134. Paludo CR, da Silva-Junior EA, Santos RA, Pupo MT, Emery FS, et al. (2013) Microbial transformation of ß-lapachone to its glycosides by Cunninghamella elegans ATCC 10028b. Phytochem Lett 6:657-661
  135. Hartmann T (1998) The fascination of alkaloids. Bioscience 49: 238-239.
  136. Abraham W-R, Spassov G (2002) Biotransformation of alkaloids: a challenge. Heterocycles 56: 711-741.
  137. Rathbone DA, Bruce NC (2002) Microbial transformation of alkaloids.Curr Opin Microbiol 5: 274-281.
  138. Boonstra B, Rathbone DA, Bruce NC (2001) Engineering novel biocatalytic routes for production of semisynthetic opiate drugs.Biomol Eng 18: 41-47.
  139. Chaudhary V, Leisch H, Moudra A, Allen B, de Luka V, et al. (2009) Biotransformations of morphine alkaloids by fungi: N-demethylations, oxidations, and reductions. Collect Czech Chem Commun 74: 1179-1193.
  140. Kyslíková E, Babiak P, Štepánek V, Zahradník J, Palyzová A, et al. (2013) Biotransformation of codeine to 14-OH-codeine by Rhizobium radiobacter R89-1. J Mol Catal B-Enzym 87: 1-5.
  141. Lü YF, Chen KY, Li HL, Pei YH, Liu RH, et al. (2008) Biotransformation of vermitaline by Cunninghamella echinulata. Helv Chim Acta 91:819-824.
  142. Devkota KP, Choudhary MI, Nawaz SA, Lannang AM, Lenta BN, et al. (2007) Microbial transformation of the steroidal alkaloid dictyophlebine by Rhizopus stolonifer.Chem Pharm Bull (Tokyo) 55: 682-684.
  143. Song CE (2009) An overview of Cinchona alkaloids in Chemistry. IN:Cinchona Alkaloids in Synthesis and Catalysis, Ligands, Immobilization and Organocatalysis,Edited by Choong Eui Song, Copyright 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
  144. Shibuya H, Kitamura C, Maehara S, Nagahata M, Winarno H, et al. (2003) Transformation of Cinchona alkaloids into 1-N-oxide derivatives by endophytic Xylaria sp isolated from Cinchona pubescens.Chem Pharm Bull (Tokyo) 51: 71-74.
  145. Chen N, Zhang J, Liu J, Yu B (2010) Highly efficient and region-selective glucosylation of 25(S) ruscogenin by Gliocladium deliquescens NRRL 1085. Chun J Chem 28: 439-442.
  146. Falcone Ferreyra ML, Rius SP, Casati P (2012) Flavonoids: biosynthesis, biological functions, and biotechnological applications.Front Plant Sci 3: 222.
  147. Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents.Med Res Rev 23: 519-534.
  148. Cao H, Chen X, Jassbi AR, Xiao J (2015) Microbial biotransformation of bioactive flavonoids.Biotechnol Adv 33: 214-223.
  149. Xiao J, Muzashvili TS, Georgiev MI (2014) Advances in the biotechnological glycosylation of valuable flavonoids.Biotechnol Adv 32: 1145-1156.
  150. Hyung Ko J, Gyu Kim B, Joong-Hoon A (2006) Glycosylation of flavonoids with a glycosyltransferase from Bacillus cereus.FEMS Microbiol Lett 258: 263-268.
  151. Plaza M, Pozzo T, Liu J, Gulshan Ara KZ, Turner C, et al. (2014) Substituent effects on in vitro antioxidizing properties, stability, and solubility in flavonoids.J Agric Food Chem 62: 3321-3333.
  152. Kostrzeva-Suslow E, Dmochowska-Gladysz J, Oszmianski J (2007) Microbial transformation of baicalin and baicalein. J Mol Catal B-Enzym 49: 113-117.
  153. Wang S, Liu G, Zhang W, Cai N, Cheng C, et al. (2014) Efficient glycosylation of puerarin by an organic solvent-tolerant strain of Lysinibacillus fusiformis. Enzyme Microb Tech 57: 42-47.
  154. Ma B, Zeng J, Shao L, Zhan J (2013) Efficient bioconversion of quercetin into a novel glycoside by Streptomyces rimosus subsp. rimosus ATCC 10970.J Biosci Bioeng 115: 24-26.
  155. Zi J, Valiente J, Zeng J, Zhan J (2011) Metabolism of quercetin by Cunninghamella elegans ATCC 9245.J Biosci Bioeng 112: 360-362.
  156. Di Carlo G, Mascolo N, Izzo AA, Capasso F (1999) Flavonoids: old and new aspects of a class of natural therapeutic drugs.Life Sci 65: 337-353.
  157. Sharma DK (2006) Pharmacological properties of flavonoids including flavonolignans – integration of petrocrops with drug development from plants. J Sci Ind Res 65: 477-484
  158. Mahmoud YA, Assawah SW, El-Sharkawy SH, Abdel-Salam A (2008) Flavone Biotransformation by Aspergillus niger and the Characterization of Two Newly Formed Metabolites.Mycobiology 36: 121-133.
  159. Canedo EM, Fill TP, Pereira-Filho ER, Rodrigues-Filho E (2014) Enzymatic potential of Mucor inaequisporus for naringin biotransformation, accessed by fractional factorial design and mass spectrometry analysis. J Anal Bioanal Techniques S6: 006.
  160. Ye H, Xu H, Yu C, dai Y, Liu G, et al. (2009) Hydroxylation of naringin by Trichoderma harzianum to dramatically improve its antioxidative activity. Enz Microb Technol 45: 282–287
  161. Roh C, Kang C (2014) Production of anti-cancer agent using microbial biotransformation.Molecules 19: 16684-16692.
  162. Revathi K, Prabha A (2015) Antibacterial and antioxidant activities of biotransformed resveratrol by Geotrichum histeridarum. Int J Curr Res Biosci Plant Biol 2: 60-66.
  163. Cichewicz RH, Kouzi SA (1998) Biotransformation of resveratrol to piceid by Bacillus cereus.J Nat Prod 61: 1313-1314.
  164. Romero-Pérez AI, Ibern-Gómez M, Lamuela-Raventós RM, de La Torre-Boronat MC (1999) Piceid, the major resveratrol derivative in grape juices.J Agric Food Chem 47: 1533-1536.
  165. Simanjuntak P, Prana TK, Wulandari D, Dharmawan A, Sunitro E, et al. (2010) Chemical studies on a curcumine analogue produced by endophytic fungal transformation. Asian Journal of Applied Sciences 3: 60-66
  166. Maehara S, Ikeda M, Haraguchi H, Kitamura C, Nagoe T, et al. (2011) Microbial conversion of curcumin into colorless hydroderivatives by the endophytic fungus Diaporthe sp. associated with Curcuma longa.Chem Pharm Bull (Tokyo) 59: 1042-1044.
  167. Zhang W, Huang J, Wo X, Wang P (2013) Microbial transformation of curcumin to its derivatives with a novel Pichia kudriavzevii ZJPH0802 strain.Appl Biochem Biotechnol 170: 1026-1037.
  168. Joo SS, Won TJ, Nam SY, Kim YB, Lee YC, et al. (2009) Therapeutic advantages of medicinal herbs fermented with Lactobacillus plantarum, in topical application and its activities on atopic dermatitis.Phytother Res 23: 913-919.
  169. Chao SH, Huang HY, Chang CH, Yang CH, Cheng WS, et al. (2013) Microbial diversity analysis of fermented mung beans (Lu-Doh-Huang) by using pyrosequensing and culture methods. PLoS One 8: e63816.
  170. Lee SJ, Kim Y, Kim MG (2015) Changes in the ginsenoside content during the fermentation process using microbial strains.J Ginseng Res 39: 392-397.
  171. Liu CY, Zhou RX, Sun CK, Jin YH, Yu HS, et al. (2015) Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848.J Ginseng Res 39: 221-229.
  172. Chu H, Jin G, Friedman E, Zhen X (2008) Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.Cell Mol Neurobiol 28: 491-499.
  173. Ge HX, Zhang J, Kai C, Liu JH, Yu BY (2012) Regio- and enantio-selective glycosylation of tetrahydroprotoberberines by Gliocladium deliquescens NRRL1086 resulting in unique alkaloidal glycosides.Appl Microbiol Biotechnol 93: 2357-2364.
  174. Ma X, Tan C, Zhu D, Gang DR, Xiao P (2007) Huperzine A from Huperzia species--an ethnopharmacolgical review.J Ethnopharmacol 113: 15-34.
  175. Zhang X, Zou Jh, Dai J (2010) Microbial transformation of (-)-Huperzine A. Tetrahedron Lett 51: 3840-3842.
  176. Ning N, Hu JF, Yuan YH, Zhang XY, Dai JG, et al. (2012) Huperzine A derivative M3 protects PC12 cells against sodium nitroprusside-induced apoptosis.Acta Pharmacol Sin 33: 34-40.
  177. Ying YM, Shan WG, Zhan ZJ (2014) Biotransformation of huperzine A by a fungal endophyte of Huperzia serrata furnished sesquiterpenoid-alkaloid hybrids.J Nat Prod 77: 2054-2059.
  178. Li H, Ye M, Guo H, Tian Y, Zhang J, et al. (2009) Biotransformation of 20(S)-protopanaxadiol by Mucor spinosus.Phytochemistry 70: 1416-1420.
  179. Ye L, Zhang C, Li J, Shi X, Feng M (2012) Effects of external calcium on the biotransformation of ginsenoside Rb1 to ginsenoside Rd by Paecilomyces bainier 229-7.World J Microbiol Biotechnol 28: 857-863.
  180. He X, Qiao A, Liu B, Wang X, Wang G, et al. (2006) Bioconversion of metyl protodioscin by Penicillium melini cells. Enzyme Microb Tech 38: 400-406.
  181. Sheldon R (2010) Introduction to green chemistry, organic synthesis and pharmaceuticals. In: Green Chemistry in the Pharmaceutical Industry. Edited by Peter J Dunn, Andrew S Wells and Michael T Williams. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Citation: Mutafova B, Mutafov S, Fernandes P, Berkov S (2016) Microbial Transformations of Plant Origin Compounds as a Step in Preparation of Highly Valuable Pharmaceuticals. J Drug Metab Toxicol 7:204.

Copyright: © 2016 Mutafova B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top